We investigate organoids, the latest way that scientists are growing cancer cells in the lab to help test hundreds of cancer drugs.
Advanced imaging technology is helping our scientists understand how key molecules fuel the growth of breast cancer cells.
Inherited gene faults are more common among men with advanced prostate cancer than in those with localised disease.
Discussing how the idea for a new drug can come from many different avenues.
From immunotherapy to targeted cancer treatment, here's our round up of the big news from the annual ASCO conference.
Tackling brain tumours, understanding immunotherapy and revealing cancer’s genetics at the end of life – accelerating progress at our Centres
We've announced four new awards to speed up research in our Centres, particularly for cancers where survival is still poor.
We look back on the key topics and trends discussed at the American Association of Cancer Research's recent Annual Meeting in New Orleans
We explore the latest research from our scientists in Manchester that's tracking how melanomas respond to treatment by analysing patient blood samples.
A new study from our scientists has found that treating melanoma cells with an HIV drug could make them more sensitive to a 'targeted' cancer drug.
From immunotherapy to 'targeted' drugs, we report back from a recent conference on lung cancer.